Phase I/II Study of Concurrent Cisplatin, Pemetrexed, and Radiotherapy for Limited Stage Small Cell Lung Cancer

Update Il y a 4 ans
Reference: EUCTR2006-003007-39

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of the phase I part of this study is to determine the recommended Phase 2 dose of pemetrexed, cisplatin, and involved-field radiotherapy in the treatment of patients with LS-SCLC. The primary objective of the phase II part of this study is to further delineate the activity of this regimen at the recommended dose in terms of overall response rate


Inclusion criteria

  • Limited Stage Small Cell Lung Cancer